Back to search

Article

Improved HLA-based prediction of coeliac disease identifies two novel HLA risk modifiers, DQ6.2 and DQ7.3

2019-03-05

Abstract excerpt

<h4>Purpose</h4> Human Leukocyte Antigen (HLA) testing is useful in the clinical work-up of coeliac disease (CD), with high negative but low positive predictive value. We construct a genomic risk score (GRS) using HLA risk loci to improve CD prediction and guide exclusion criteria. <h4>Methods</h4> Imputed HLA genotypes for five European CD case-control GWAS (n>15,000) were used to construct and validate an HLA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
49f6bb22-fc03-5456-8956-7571d8de089f
DOI
10.1101/561308
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improved HLA-based prediction of coeliac disease identifies two novel HLA risk modifiers, DQ6.2 and DQ7.3DOI 10.1101/561308
Select a neighboring publication to make it the new centre.